• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Terns Pharmaceuticals, Inc. (TERN) Stock Price, News & Analysis

Terns Pharmaceuticals, Inc. (TERN) Stock Price, News & Analysis

Currency in USD Disclaimer

$5.72

$0.12

(2.05%)

Day's range
$5.46
Day's range
$5.79
50-day range
$5.46
Day's range
$10.7
  • Country: US
  • ISIN: US8808811074
52 wk range
$3.59
Day's range
$11.4
  • CEO: Ms. Amy L. Burroughs M.B.A.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 19.54
  • Piotroski Score 3.00
  • Grade Market Outperform
  • Symbol (TERN)
  • Company Terns Pharmaceuticals, Inc.
  • Price $5.72
  • Changes Percentage (2.05%)
  • Change $0.12
  • Day Low $5.46
  • Day High $5.79
  • Year High $11.40

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/12/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $12.00
  • High Stock Price Target $26.00
  • Low Stock Price Target $7.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.26
  • Trailing P/E Ratio -5.67
  • Forward P/E Ratio -5.67
  • P/E Growth -5.67
  • Net Income $-90,210,000

Income Statement

Quarterly

Annual

Latest News of TERN

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Terns Pharmaceuticals, Inc. Frequently Asked Questions

  • What were the earnings of TERN in the last quarter?

    In the last quarter Terns Pharmaceuticals, Inc. earnings were on Monday, August, 5th. The Terns Pharmaceuticals, Inc. maker reported -$0.31 EPS for the quarter, beating analysts' consensus estimates of -$0.35 by $0.04.

  • What is the Terns Pharmaceuticals, Inc. stock price today?

    Today's price of Terns Pharmaceuticals, Inc. is $5.72 — it has increased by +2.05% in the past 24 hours. Watch Terns Pharmaceuticals, Inc. stock price performance more closely on the chart.

  • Does Terns Pharmaceuticals, Inc. release reports?

    Yes, you can track Terns Pharmaceuticals, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Terns Pharmaceuticals, Inc. stock forecast?

    Watch the Terns Pharmaceuticals, Inc. chart and read a more detailed Terns Pharmaceuticals, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Terns Pharmaceuticals, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Terns Pharmaceuticals, Inc. stock ticker.

  • How to buy Terns Pharmaceuticals, Inc. stocks?

    Like other stocks, TERN shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Terns Pharmaceuticals, Inc.'s EBITDA?

    Terns Pharmaceuticals, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Terns Pharmaceuticals, Inc.’s financial statements.

  • What is the Terns Pharmaceuticals, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Terns Pharmaceuticals, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Terns Pharmaceuticals, Inc.'s financials relevant news, and technical analysis. Terns Pharmaceuticals, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Terns Pharmaceuticals, Inc. stock currently indicates a “sell” signal. For more insights, review Terns Pharmaceuticals, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.